Update on desensitization to chemotherapeutics and biologicals
- 3 April 2026
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 136 (4) , 422-423
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Update on desensitization to chemotherapeutics and biologicalsAnnals of Allergy, Asthma & Immunology, 2025
- One-bag protocol for cancer drug hypersensitivityAnnals of Allergy, Asthma & Immunology, 2025
- Epinephrine infusion as an adjuvant treatment for breakthrough reactions during desensitization to methotrexateWorld Allergy Organization Journal, 2024
- Severe anaphylaxis requiring continuous adrenaline infusion during oral food challengeAnnals of Allergy, Asthma & Immunology, 2024
- Anaphylaxis: A 2023 practice parameter updateAnnals of Allergy, Asthma & Immunology, 2023
- Comparison of the efficacy of continuous intravenous infusion versus intramuscular injection of epinephrine for initial anaphylaxis treatmentAcute Medicine & Surgery, 2022
- One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year ExperienceThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Hypersensitivity reactions to chemotherapy: an EAACI Position PaperAllergy, 2021
- Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogsClinical & Experimental Allergy, 2004